- Human pathology

Home > E. Pathology by systems > Respiratory system > Lungs > BRAF-mutated pulmonary adenocarcinoma

BRAF-mutated pulmonary adenocarcinoma

Thursday 27 June 2019

BRAF mutation is not a strong prognostic factor in NSCLC.


- Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France study. Couraud S, Barlesi F, Fontaine-Deraluelle C, Debieuvre D, Merlio JP, Moreau L, Beau-Faller M, Veillon R, Mosser J, Al Freijat F, Bringuier PP, Léna H, Ouafik L, Westeel V, Morel A, Audigier-Valette C, Missy P, Langlais A, Morin F, Souquet PJ, Planchard D; Biomarkers France Contributors. Eur J Cancer. 2019 Jun 7;116:86-97. doi : 10.1016/j.ejca.2019.04.016 PMID: 31181537